Dietary Approaches to the Management Of type 2 Diabetes (DIAMOND) in primary care: a protocol for a cluster randomised trial

Journal article

Introduction: There is strong evidence that type 2 diabetes (T2D) remission can be achieved by adopting a low-energy diet achieved through total dietary replacement products. There is promising evidence that low-carbohydrate diets can achieve remission of T2D. The Dietary Approaches to the Management of type 2 Diabetes (DIAMOND) programme combines both approaches in a behaviourally informed low-energy, low-carbohydrate diet for people with T2D, delivered by nurses in primary care. This trial compares the effectiveness of the DIAMOND programme to usual care in inducing remission of T2D and in reducing risk of cardiovascular disease.

Methods and analysis: We aim to recruit 508 people in 56 practices with T2D diagnosed within 6 years, who are demographically representative of the UK population. We will allocate general practices, based on ethnicity and socioeconomic status, to provide usual care for diabetes or offer the DIAMOND programme. Participants in practices offering DIAMOND will see the nurse seven times over 6 months. At baseline, 6 months, and 1 year we will measure weight, blood pressure, HbA1c, lipid profile and risk of fatty liver disease. The primary outcome is diabetes remission at 1 year, defined as HbA1c < 48 mmol/mol and off glucose-lowering medication for at least 6 months. Thereafter, we will assess whether people resume treatment for diabetes and the incidence of microvascular and macrovascular disease through the National Diabetes Audit. Data will be analysed using mixed-effects generalised linear models.

This study has been approved by the National Health Service Health Research Authority Research Ethics Committee (Ref: 22/EM/0074).

Trial Registration number: ISRCTN46961767.

Authors: Scragg, J; Morris, E; Wane, S; Noreik, M; Jerome, D

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Elsevier
• Journal: Contemporary Clinical Trials
• Volume: 129
• Article number: 107199
• Place of publication: United States
• Publication date: 2023-04-23
• Acceptance date: 2023-04-14
• DOI: 10.1016/j.cct.2023.107199
• EISSN: 1559-2030
• ISSN: 1551-7144
• Pmid: 37094737
• Language: English
• Keywords: state medicine; randomized controlled trials as topic; diet; diabetes mellitus; FFR; glycated hemoglobin; primary health care; carbohydrate-restricted; type 2